---
figid: PMC4171341__nihms619456f3
figtitle: 'Change or Die: Targeting Adaptive Signaling to Kinase Inhibition in Cancer
  Cells'
organisms:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC4171341
filename: nihms619456f3.jpg
figlink: /pmc/articles/PMC4171341/figure/F3/
number: F3
caption: A. PI3K can become active, under physiologic conditions, via upstream RTK
  signaling and/or RAS. Activation of PI3K leads to downstream signal amplification
  through AKT and mTOR, resulting in increased protein translation, proliferation
  and survival. The PI3K/AKT/mTOR signaling axis can regulate its own activity through
  the negative feedback loops shown, as well as from negative pathway regulators PTEN
  and NF-1. B. Known nodes within the pathway mutated/hyperactivated in cancer are
  shown. C. Adaptive signaling in response to PI3K/AKT/mTOR inhibition is shown, resulting
  in therapy evasion.
papertitle: 'Change or Die: Targeting Adaptive Signaling to Kinase Inhibition in Cancer
  Cells.'
reftext: Vito W. Rebecca, et al. Biochem Pharmacol. ;91(4):417-425.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9377372
figid_alias: PMC4171341__F3
figtype: Figure
redirect_from: /figures/PMC4171341__F3
ndex: 7950f2bd-df05-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4171341__nihms619456f3.html
  '@type': Dataset
  description: A. PI3K can become active, under physiologic conditions, via upstream
    RTK signaling and/or RAS. Activation of PI3K leads to downstream signal amplification
    through AKT and mTOR, resulting in increased protein translation, proliferation
    and survival. The PI3K/AKT/mTOR signaling axis can regulate its own activity through
    the negative feedback loops shown, as well as from negative pathway regulators
    PTEN and NF-1. B. Known nodes within the pathway mutated/hyperactivated in cancer
    are shown. C. Adaptive signaling in response to PI3K/AKT/mTOR inhibition is shown,
    resulting in therapy evasion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - HRAS
  - NRAS
  - IRS2
  - IRS1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - NF1
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - BAD
  - MTOR
  - ULK1
  - RPS6KB1
  - ras
  - Hras
  - Kras
  - Rem1
  - Irs2
  - Irs1
  - Pik3r1
  - Ecm1
  - Ppp1r13b
  - Pik3ca
  - Nf1
  - Pten
  - Akt1
  - Bad
  - Mtor
  - Ulk1
  - Rps6kb1
  - Pain1
  - Ras64B
  - Ras85D
  - Tie
  - InR
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Myb
  - Taf5
  - l(1)G0020
  - Taf4
  - Rpn2
  - Sap-r
  - Akt
  - foxo
  - cass
  - Tor
  - Atg1
  - S6k
  - Cancer
  - Lung cancer
---
